1. Home
  2. SHEN vs AQST Comparison

SHEN vs AQST Comparison

Compare SHEN & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shenandoah Telecommunications Co

SHEN

Shenandoah Telecommunications Co

HOLD

Current Price

$12.26

Market Cap

635.1M

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.58

Market Cap

529.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEN
AQST
Founded
1902
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
635.1M
529.4M
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
SHEN
AQST
Price
$12.26
$4.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$26.00
$9.00
AVG Volume (30 Days)
478.6K
3.2M
Earning Date
05-01-2026
05-01-2026
Dividend Yield
0.73%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$357,854,000.00
$67,430,000.00
Revenue This Year
$7.12
$10.08
Revenue Next Year
N/A
$49.60
P/E Ratio
N/A
N/A
Revenue Growth
9.08
0.77
52 Week Low
$9.67
$2.94
52 Week High
$17.35
$7.55

Technical Indicators

Market Signals
Indicator
SHEN
AQST
Relative Strength Index (RSI) 43.15 66.91
Support Level $10.94 $4.03
Resistance Level $16.89 $4.69
Average True Range (ATR) 0.62 0.24
MACD 0.01 0.08
Stochastic Oscillator 26.28 87.72

Price Performance

Historical Comparison
SHEN
AQST

About SHEN Shenandoah Telecommunications Co

Shenandoah Telecommunications Co with its subsidiaries, provides various broadband communication products and services via its wireless, cable, fiber optic, and fixed wireless networks to customers in the Mid-Atlantic United States. The company operates through one business unit: Broadband. The broadband segment provides broadband Internet, video, and voice services to residential and commercial customers. The broadband segment generates the vast majority of the company's revenue, with the bulk of sales flowing from residential and small, and medium businesses within the broadband unit.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: